Neurocrine Biosciences shares owned by Bnp Paribas Investment Partners
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Bnp Paribas Investment Partners
from 13F filings
Historical chart of Bnp Paribas Investment Partners investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Bnp Paribas Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Bnp Paribas Investment Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $95M | 721k | 131.76 |
| 2023-09-30 | $76M | 678k | 112.50 |
| 2023-06-30 | $62M | 657k | 94.30 |
| 2023-03-31 | $62M | 613k | 101.22 |
| 2022-12-31 | $66M | 551k | 119.45 |
| 2022-09-30 | $57M | 534k | 106.21 |
| 2022-06-30 | $44M | 448k | 97.48 |
| 2022-03-31 | $34M | 359k | 93.71 |
| 2021-12-31 | $32M | 373k | 85.17 |
| 2021-09-30 | $38M | 392k | 95.91 |
| 2021-06-30 | $38M | 393k | 97.32 |
| 2021-03-31 | $32M | 324k | 97.25 |
| 2020-12-31 | $25M | 258k | 95.85 |
| 2020-09-30 | $25M | 264k | 96.16 |
| 2020-06-30 | $27M | 221k | 122.00 |
| 2020-03-31 | $20M | 236k | 86.55 |
| 2019-12-31 | $22M | 203k | 107.49 |
| 2019-09-30 | $27M | 298k | 90.11 |
| 2019-06-30 | $34M | 405k | 84.43 |
| 2019-03-31 | $32M | 367k | 88.10 |
| 2018-12-31 | $12M | 181k | 68.43 |
| 2018-09-30 | $24M | 193k | 122.95 |
| 2018-06-30 | $24M | 246k | 98.24 |
| 2018-03-31 | $9.1M | 110k | 82.93 |
| 2017-12-31 | $20M | 251k | 77.59 |
| 2017-09-30 | $32M | 523k | 61.28 |
| 2017-06-30 | $18M | 390k | 46.00 |
| 2017-03-31 | $9.1M | 209k | 43.30 |
| 2016-12-31 | $7.2M | 185k | 38.70 |
| 2016-09-30 | $8.6M | 171k | 50.64 |
| 2016-06-30 | $8.3M | 183k | 45.45 |
| 2016-03-31 | $2.3M | 59k | 39.55 |
| 2015-03-31 | $684k | 17k | 39.70 |
| 2014-12-31 | $421k | 19k | 22.32 |
| 2013-09-30 | $2.1M | 184k | 11.32 |
| 2013-06-30 | $3.2M | 241k | 13.38 |
More positions owned by Bnp Paribas Investment Partners
View all positions for Bnp Paribas Investment Partners